Neil E Kay Selected Research

Neil E Kay Research Topics

Disease

99	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 10/2002
34	Neoplasms (Cancer) 02/2024 - 01/2004
21	Disease Progression 04/2024 - 03/2004
9	Lymphocytosis 02/2024 - 01/2013
8	Lymphoma (Lymphomas) 01/2022 - 08/2004
8	Leukemia 06/2015 - 12/2003
7	Infections 04/2024 - 01/2004
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 04/2007
5	Multiple Myeloma 01/2022 - 05/2002
5	Residual Neoplasm 01/2022 - 01/2007
5	Chromosome Aberrations (Chromosome Abnormalities) 07/2014 - 09/2006
3	COVID-19 04/2024 - 12/2022
3	Cytokine Release Syndrome 10/2023 - 01/2019
3	Atrial Fibrillation 01/2021 - 01/2017
3	Fatigue 12/2018 - 10/2013
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 09/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 10/2011
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2021
2	Tumor Lysis Syndrome 10/2020 - 12/2018
2	Diarrhea 12/2018 - 07/2014
2	Cytopenia 11/2018 - 04/2010
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2018 - 02/2006
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2015 - 07/2010
2	Lymphoid Leukemia 07/2014 - 12/2003
2	Autoimmune Diseases (Autoimmune Disease) 01/2011 - 06/2009
2	Hypoxia (Hypoxemia) 03/2010 - 04/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2006 - 12/2003
1	Human Influenza (Influenza) 12/2021
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Trisomy (Trisomies) 01/2020
1	Neuroinflammatory Diseases 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019

Drug/Important Bio-Agent (IBA)

21	ibrutinibIBA 10/2023 - 07/2014
17	Rituximab (Mabthera)FDA Link 10/2023 - 01/2007
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2002
9	Pentostatin (Nipent)FDA LinkGeneric 01/2019 - 01/2004
8	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 08/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2007
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2007
7	Immunoglobulins (Immunoglobulin)IBA 01/2015 - 05/2002
6	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2019
5	VaccinesIBA 04/2024 - 07/2014
5	Monoclonal AntibodiesIBA 04/2024 - 02/2004
5	venetoclaxIBA 10/2022 - 01/2020
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 08/2004
4	serum P-component (CIt)IBA 01/2023 - 11/2013
4	Alemtuzumab (Campath)FDA Link 01/2019 - 10/2008
4	ofatumumab FDA Link 12/2018 - 03/2011
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2024 - 01/2015
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023 - 02/2011
3	AntigensIBA 01/2022 - 01/2008
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 03/2013
3	B-Cell Maturation AntigenIBA 01/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2006
3	Prednisone (Sone)FDA LinkGeneric 09/2015 - 01/2004
3	MicroRNAs (MicroRNA)IBA 06/2015 - 01/2011
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 01/2013
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 07/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 07/2010
2	fludarabineIBA 01/2019 - 01/2009
2	Bendamustine Hydrochloride FDA Link 08/2017 - 01/2015
2	idelalisibIBA 05/2015 - 01/2013
2	TeaIBA 01/2013 - 08/2004
2	polyphenon EIBA 01/2013 - 08/2009
2	IntegrinsIBA 01/2013 - 10/2011
2	Protein Kinases (Protein Kinase)IBA 01/2011 - 09/2006
2	purineIBA 04/2010 - 04/2006
2	Complement System Proteins (Complement)IBA 06/2009 - 12/2008
2	Chlorambucil (Leukeran)FDA Link 01/2009 - 01/2004
2	NF-kappa B (NF-kB)IBA 11/2008 - 07/2007
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2008 - 08/2004
2	B-Cell Activating FactorIBA 02/2006 - 10/2002
1	CytokinesIBA 04/2024
1	COVID-19 VaccinesIBA 04/2024
1	tafasitamabIBA 10/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	CI 22IBA 10/2022
1	Herpes Zoster VaccineIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	ChemokinesIBA 01/2021
1	3- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA 01/2021
1	Exportin 1 ProteinIBA 01/2021
1	CateninsIBA 01/2021
1	Biological FactorsIBA 12/2020
1	Long Noncoding RNAIBA 01/2019
1	IGF-I-IGFBP-3 complex FDA Link 01/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Axl Receptor Tyrosine KinaseIBA 12/2018

Therapy/Procedure

46	Therapeutics 04/2024 - 01/2004
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 02/2009 - 04/2006
2	Immunotherapy 10/2023 - 05/2013
2	Aftercare (After-Treatment) 01/2019 - 01/2009
1	Radiotherapy 11/2023